NLC Health Ventures and Rambam AG have announced the pre-seed funding and launch of NeurOdys Therapeutics, a biotechnology startup focused on developing treatments for neurodegenerative disorders.
Target Company Overview
NeurOdys Therapeutics, headquartered in Amsterdam, Netherlands, is a pioneering biotechnology startup focused on developing innovative treatments for neurodegenerative disorders. Founded with pre-seed funding from NLC Health Ventures and Rambam AG, NeurOdys aims to tackle some of the most challenging issues in neurology.
The company boasts a talented team of scientists, drug developers, and investors dedicated to discovering novel small molecules that can alter disease progression and enhance patient outcomes for conditions such as Alzheimer’s and Parkinson’s disease.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The biotechnology industry in the Netherlands is one of the leading sectors in Europe, known for its robust research capabilities and innovative companies. The country fosters a thriving ec
Similar Deals
Capricorn Partners, Oost NL, Angel Investor → InsectSense
2023
Capricorn Partners, Oost NL and an angel investor → InsectSense
819 Capital Partners → RiverD International
2026
NLC Health Ventures
invested in
NeurOdys Therapeutics
in
in a Pre-Seed Stage deal